Plastic surgery practice succession planning is the part of an exit most surgeons put off longest. It’s easy to see why. When you’re booked months out and your reputation is at its peak, planning for the day you stop operating feels premature. But succession isn’t a single event. It’s a process that takes years, and the surgeons who start early are the ones who get to choose how it ends.
This guide covers the main succession paths, how an associate buy-in compares with a sale to an outside buyer, how to structure a partnership track, the agreements that protect everyone, and a seven-step plan. It supports our main guide on how to sell a plastic surgery practice.
Key takeaways
- Physicians are aging. The AAMC reports that 23.9% of active US physicians were 65 or older in 2024 (AAMC).
- The main paths are an internal associate buy-in, a sale to an outside buyer, or a hybrid where an associate joins a buyer’s platform.
- A strong successor raises your value to outside buyers too, because it reduces key-surgeon risk.
- Start five years ahead if you want an internal transition. Associate buy-ins take time to work.
What is plastic surgery practice succession planning?
Plastic surgery practice succession planning is the process of deciding who will own and run your practice when you step back, and preparing the practice, the people and the agreements to make that handover work. It covers internal successors, outside buyers, timing, valuation and what happens if you’re suddenly unable to practice.
Good succession planning answers three questions. Who takes over clinical care for your patients? Who owns the business? And how do you get paid for what you’ve built? Sometimes one person answers all three, as in a classic associate buy-in. Increasingly, the answers are split between an associate who takes over clinically and an outside buyer who owns the business.
Why does succession planning matter now?
Because the physician workforce is aging and buyers pay for practices that don’t depend on one surgeon. The AAMC reports nearly a quarter of active physicians were 65 or older in 2024. A practice with a credible successor is worth more, sells faster and protects patients if the founder can’t operate.
The AAMC’s earlier workforce data showed that 44.9% of physicians were 55 or older in 2019, up from 37.6% in 2007. At the same time, buyers keep flagging key man risk. TUSK Practice Sales says buyers want an associate or partner surgeon who can step in if the founder leaves (PR Newswire). Succession planning solves both problems at once.
Associate buy-in vs sale: which is right for you?
An associate buy-in usually suits surgeons who want continuity, gradual exit and a successor they’ve trained. A sale to an outside buyer usually suits surgeons who want the highest price, faster liquidity or who have no internal candidate. Many surgeons now combine the two, bringing in an associate who stays after a sale.
| Factor | Associate buy-in | Sale to outside buyer |
| Price | Often lower, based on an agreed formula | Often higher, set by competition |
| Timing of payment | Spread over years | Mostly at closing, plus any rollover |
| Continuity | High: a surgeon you chose continues | Depends on the buyer |
| Your control during transition | High | Shared or reduced |
| Financing risk | Associate must fund the purchase | Buyer funds it |
| Best when | You have a strong internal candidate | You want maximum value or have no successor |
Neither is automatically better. The right answer depends on your goals, your associate’s ability and willingness to buy, and what outside buyers would pay. Our guide to plastic surgery practice valuation explains how to benchmark an internal price against the market.
Partnership track vs selling the practice
A partnership track brings an associate in as an employee with a defined path to ownership, usually after a few years and once they meet agreed targets. Selling the practice transfers ownership now. A partnership track protects continuity and lets both sides test the fit. A sale delivers value sooner but hands decisions to someone else.
A partnership track works best when it’s written down. Associates who are promised “partnership someday” often leave for a practice that puts the terms in writing. Spell out the timeline, the price or valuation method, how the buy-in is funded and what happens if either side changes their mind.
How do you choose the right successor?
Look beyond surgical skill. The right successor shares your standards for patient care, fits your team, wants to own a business and not just operate, and has the temperament to handle staff, marketing and finances. A brilliant surgeon who has no interest in running a practice is an employee, not a successor.
Questions worth asking any candidate:
- Do they want ownership, and can they realistically finance it?
- How do patients respond to them in consultations?
- How do they handle complications, complaints and difficult staff conversations?
- Do they want to stay in your community for the long term?
- Are their aesthetic sensibilities close enough to yours that your patients will trust them?
Give it time before committing. A few years working side by side tells both of you more than any interview.
How does an associate buy-in work?
The associate joins as an employee, builds a caseload, then buys an ownership stake in stages at a price set by an agreed valuation method. Payments may come from a bank loan, a seller note, salary adjustments or a mix. Over time the founder’s share falls until the associate owns a majority or all of the practice.
Common building blocks:
- Employment period. Often two to three years before any purchase, so both sides can judge the fit.
- Valuation method. An independent appraisal, a formula based on earnings, or a fixed price reset each year.
- Staged purchase. For example, a minority stake first, then additional tranches.
- Funding. Healthcare lenders, seller financing or reduced compensation during the buy-in.
- Governance. Who decides what at each stage, and how disputes are resolved.
Here’s a hypothetical example, with illustrative figures only: a founder sells 30% to an associate in year three, another 30% in year five and the remaining 40% in year seven, each at an appraised value. The founder keeps operating part-time through year seven, then retires with the associate fully in charge.
Can you combine succession planning with a private equity sale?
Yes, and it’s increasingly common. You sell to a private equity-backed platform, receive cash and rollover equity, and your associate joins the platform with their own employment agreement and sometimes equity. The associate becomes your clinical successor while the platform owns the business, which buyers often value highly.
This hybrid path can give you a higher price than an internal buy-in, while still putting a surgeon you trust in charge of your patients. It also answers the key man question directly, because the buyer sees a successor already in place. Make sure your associate’s terms are negotiated alongside yours, not left for later.
7 steps to a plastic surgery practice succession plan
1. Set your timeline
Decide roughly when you want to reduce your schedule and when you want to stop operating. An internal transition usually needs about five years. An outside sale can happen faster if the practice is ready.
2. Get a valuation
Know what your practice is worth today and what drives that value. This anchors any internal price and tells you what an outside buyer might pay.
3. Identify or recruit a successor
Look for a surgeon whose skills, values and patient manner fit your practice, and who wants ownership. Recruiting takes time, so start early.
4. Put the terms in writing
Document the partnership track, valuation method, funding and timeline. Vague promises are the most common reason associate relationships fail.
5. Transfer patient relationships gradually
Introduce your associate in consultations, share follow-ups and let them build their own reputation. Patients follow trust, and trust takes time.
6. Sign a buy-sell agreement
Cover death, disability, retirement, divorce and disputes. Fund it with insurance where appropriate, so a sudden event doesn’t force a fire sale.
7. Revisit the plan every year
Goals change, markets change and associates change their minds. An annual review keeps the plan realistic. Our guide to how to prepare a plastic surgery practice for sale covers the operational steps that support any path.
What should a buy-sell agreement include?
A buy-sell agreement sets out what happens to ownership if an owner dies, becomes disabled, retires, divorces, leaves or is removed. It should define triggering events, the valuation method, who can buy, how the purchase is funded and the payment terms. It protects the practice, the remaining owners and your family.
Without one, a sudden illness or death can leave your family negotiating with your associate, or with a buyer, under pressure. Life and disability insurance often funds these agreements. Have a healthcare attorney draft it, and update it whenever ownership changes.
What about non-competes for associates?
Associates often sign non-competes, but state laws increasingly limit them for physicians. The AMA reports, for example, that Texas limits physician non-competes to one year and five miles and Pennsylvania to one year. Terms that are too restrictive may be unenforceable, and they can also discourage good candidates.
A fair non-compete protects the practice you’re building for your successor without trapping them. See the AMA’s summary of state actions and ask your attorney what’s enforceable in your state. Our guide to the post-close employment agreement for surgeons covers non-competes after a sale.
Frequently asked questions
When should I start plastic surgery practice succession planning?
Ideally five years before you want to stop operating, and earlier if you plan an internal transition. Recruiting an associate, letting them build a caseload and completing a staged buy-in all take time. Even if you plan an outside sale, having a successor in place raises your value and protects patients.
Is an associate buy-in or a sale better?
It depends on your goals. An associate buy-in offers continuity and a gradual exit, usually at a lower price paid over time. A sale to an outside buyer often brings a higher price and faster liquidity but less control. Many surgeons combine them by selling to a buyer while an associate stays on.
How is the price set in an associate buy-in?
Usually through an agreed valuation method, such as an independent appraisal, an earnings-based formula or a fixed price reset annually. Many practices benchmark against what outside buyers would pay, then discount for the associate’s risk and financing. Put the method in writing before the associate starts buying.
What happens to my practice if I become disabled suddenly?
Without a plan, your family may be forced to sell quickly at a low price. A buy-sell agreement funded with disability and life insurance sets the terms in advance, and a trained associate can keep patient care going. That protection is one of the strongest reasons to plan succession early.
Can my associate join a private equity buyer after I sell?
Yes. Many private equity-backed platforms welcome associates as part of the deal, offering them employment agreements and sometimes equity. Buyers often value a successor already in place because it reduces key-surgeon risk. Negotiate your associate’s terms at the same time as yours so their future is clear.
What is the difference between succession planning and exit planning?
Exit planning covers everything about leaving your practice, including timing, taxes, valuation and the sale process. Succession planning focuses on who takes over clinical care and ownership. They overlap heavily, and the best plans handle both together, so the practice has a successor and you have a clear financial outcome.
Plastic surgery practice succession planning: the bottom line
Plastic surgery practice succession planning works best when it starts early, is written down and is revisited every year. Whether you choose an associate buy-in, an outside sale or a hybrid, a credible successor protects your patients, raises your value and lets you leave on your own terms.
| Thinking about your succession plan? Get the Plastic Surgery Exit Report newsletter for quarterly deal data, or book a confidential conversation with the plastic surgery team at Olympic M&A. Disclosure: Plastic Surgery Exit Report is published in partnership with Olympic M&A, a healthcare M&A advisory firm. |
